Implanet ALIMP.PA · EUR

Its shares trade on Euronext Paris under the ticker ALIMP.PA. It has been listed since 25 November 2013. In the fiscal year to 31 December 2025, it reported revenue of €12.5m and a net loss of €4.4m. At that date it held total assets of €18.4m and shareholders' equity of €404,000.

Implanet SA engages in manufacturing implants designed for orthopedic surgery. The company is headquartered in Martillac, Nouvelle-Aquitaine. The company went IPO on 2013-11-25. The company is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The firm's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors, among others. Its activities, and flagship products, include JAZZ (Spine System) and MADISON (Knee implant). JAZZ implant is designed to improve the treatment of spinal pathologies requiring vertebral fusion surgery. MADISON implant is designed for first-line prosthetic knee surgery.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Mingyan LiuChairman of the Board
• Mr. Ludovic LastennetChief Executive Officer, Director, Commercial Director, since 2013€294,000
• Mr. Benjamin LetienneVice President of Marketing & International Sales, Director, since 2021
• Mr. David FanDirector
• Ms. Nuan NiDirector

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.